Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TCNNF)

CUSIP: 89788C104

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Subordinate Voting Shares, no par value
Shares outstanding
168,103,448
Total 13F shares
153,603
Share change
-12,611
Total reported value
$1,334,814
Price per share
$8.69
Number of holders
7
Value change
-$101,646
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 89788C104?
CUSIP 89788C104 identifies TCNNF - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TCNNF - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Marex Securities Products Inc.
13D/G
5.8%
9,750,000
$51,675,000 $0 16 Dec 2025
Steven Matthew White
3/4/5
President
class O/S missing
2,400,674
$12,579,532 24 May 2022
Timothy Morey
3/4/5
Chief Sales Officer
mixed-class rows
319,388
mixed-class rows
$941,681 01 Dec 2025
Giannella Alvarez
3/4/5
Director
class O/S missing
44,732
$570,731 16 May 2024
Gina Collins
3/4/5
Chief Marketing Officer
mixed-class rows
343,929
mixed-class rows
$458,230 12 Aug 2025
Alex D'Amico
3/4/5
Chief Financial Officer
class O/S missing
82,869
$434,234 29 Dec 2022
Marie Zhang
3/4/5
Chief Operating Officer
mixed-class rows
213,813
mixed-class rows
$422,772 25 Mar 2025
Joy Malivuk
3/4/5
Chief Accounting Officer
mixed-class rows
146,629
mixed-class rows
$400,417 01 Dec 2025
ALBERT D MASON INC
13F
Company
0.02%
40,093
$323,154 30 Sep 2025
13F
Ryan Blust
3/4/5
Interim CFO
mixed-class rows
155,205
mixed-class rows
$259,544 12 Aug 2025
Wes Getman
3/4/5
Chief Financial Officer
mixed-class rows
114,902
mixed-class rows
$230,770 11 Dec 2024
Vermillion & White Wealth Management Group, LLC
13F
Company
0.01%
12,441
$100,276 30 Sep 2025
13F
Rebecca L. Young
3/4/5
Chief Accounting Officer
mixed-class rows
33,589
mixed-class rows
$45,740 24 Feb 2022
Westside Investment Management, Inc.
13F
Company
0%
500
$4,200 30 Sep 2025
13F
Horrell Capital Management, Inc.
13F
Company
0%
390
$3,143 30 Sep 2025
13F
Hurley Capital, LLC
13F
Company
0%
100
$806 30 Sep 2025
13F
ORG Partners LLC
13F
Company
0%
75
$604 30 Sep 2025
13F
CROWLEY WEALTH MANAGEMENT, INC.
13F
Company
0%
70
$564 30 Sep 2025
13F
Telogia Pharm, LLC
3/4/5
10%+ Owner
class O/S missing
85,918
09 Apr 2021
Shade Leaf Holding, LLC
3/4/5
10%+ Owner
class O/S missing
80,001
15 Nov 2021

Institutional Holders of Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TCNNF) as of Q4 2025

As of 31 Dec 2025, Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TCNNF) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 153,603 shares. The largest 7 holders included NANO CAP NEW MILLENNIUM GROWTH FUND L P, ALBERT D MASON INC, Westside Investment Management, Inc., Horrell Capital Management, Inc., ORG Partners LLC, Planning Project LLC, and Garton & Associates Financial Advisors LLC. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
7
Q4 2025 holders
7
Holder diff
0
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .